|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Rockefeller University Press,
0021-9525/2001//457 $5.00
The Journal of Cell Biology, Volume 153, Number 3,
, 2001 457-464
Original Article |
Negative Regulation of the Sapk/Jnk Signaling Pathway by Presenilin 1
ejchoi{at}mail.korea.ac.kr
Presenilin 1 (PS1) plays a pivotal role in Notch signaling and the intracellular metabolism of the amyloid β-protein. To understand intracellular signaling events downstream of PS1, we investigated in this study the action of PS1 on mitogen-activated protein kinase pathways. Overexpressed PS1 suppressed the stress-induced stimulation of stress-activated protein kinase (SAPK)/c-Jun NH2-terminal kinase (JNK) in human embryonic kidney 293 cells. Interestingly, two functionally inactive PS1 mutants, PS1(D257A) and PS1(D385A), failed to inhibit UV-stimulated SAPK/JNK. Furthermore, H2O2- or UV-stimulated SAPK activity was higher in mouse embryonic fibroblast (MEF) cells from PS1-null mice than in MEF cells from PS+/+ mice. MEFPS1(–/–) cells were more sensitive to the H2O2-induced apoptosis than MEFPS1(+/+) cells. Ectopic expression of PS1 in MEFPS1(–/–) cells suppressed H2O2-stimulated SAPK/JNK activity and apoptotic cell death. Together, our data suggest that PS1 inhibits the stress-activated signaling by suppressing the SAPK/JNK pathway.
Key Words: apoptosis c-Jun NH2-terminal kinase presenilin 1
-secretase stress-activated protein kinase
© 2001 The Rockefeller University Press
| Introduction |
|---|
|
|
|---|
-secrease–mediated processing (Selkoe 1998). Most cases of early-onset familial AD (FAD) are caused by mutations in the genes encoding presenilin 1 (PS1) (Sherrington et al. 1995) and presenilin 2 (PS2) (Levy-Lahad et al. 1995; Rogaev et al. 1995). Presenilins appear to be required for the processing of APP to Aβ (by
-secretase activation) (De Strooper et al. 1998; Wolfe et al. 1999; Li et al. 2000).
PS1 is a membrane protein that contains eight putative transmembrane domains and primarily localized to intracellular membranes including the endoplasmic reticulum and Golgi apparatus (Cook et al. 1996; Doan et al. 1996; Kovacs et al. 1996; De Strooper et al. 1997). Presenilins are homologous to two Caenorhabitis elegans gene products, SEL-12 and HOP1, both of which facilitate Notch/LIN-12 signaling (Artavanis-Tsakonas et al. 1999). Indeed, PS1 plays a pivotal role in Notch signaling by regulation of the Notch processing through
-secretase activation (Levitan and Greenwald 1995; Li and Greenwald 1997; Chan and Jan 1999; De Strooper et al. 1999; Ray et al. 1999; Li et al. 2000). Notch signaling appears to be associated with the regulatory mechanisms of a variety of cellular events including cell fate control during embryonic development, differentiation, cell growth, and apoptosis (Artavanis-Tsakonas et al. 1999).
The mitogen-activated protein kinase (MAPK) pathway is one of the major signaling pathways that transmit intracellular signals initiated by extracellular stimuli to the nucleus. The MAPK pathway regulates a variety of cellular functions, including cell proliferation, differentiation, and death (Minden and Karin 1997; Ip and Davis 1998; Schaeffer and Weber 1999). The MAPK pathway includes three distinct components: MAPKs, MAPK kinases (MAPKKs), and MAPKK kinases (MAPKKKs). MAPKKKs phosphorylate and activate MAPKKs, which in turn phosphorylate and activate MAPKs. When activated, MAPKs phosphorylate various proteins that include transcription factors, thereby regulating gene expression or other cellular functions. The family of mammalian MAPKs includes three subfamilies: extracellular signal-regulated kinase (Erk), stress-activated protein kinase (SAPK)/c-Jun NH2-terminal kinase (JNK) and p38 MAPK (Boulton et al. 1991; Han et al. 1994; Cobb and Goldsmith 1995; Kyriakis and Avruch 1996; Su and Karin 1996; Fanger et al. 1997). The Erk pathway consists of Erk and upstream kinases that include MAPK/Erk kinase 1 and Raf-1 (Schaeffer and Weber 1999). This pathway is often stimulated by mitogenic stimuli. The p38 MAPK pathway consists of p38 MAPK and its upstream kinases that include MAPKKs such as MKK3 or MKK6 and MAPKKK such as ASK1 or TAK1 (Schaeffer and Weber 1999). The SAPK/JNK pathway consists of SAPK/JNK and upstream kinases that include MAPKKs such as SEK1/JNKK1/MKK4 or MKK7, and MAPKKKs such as MEKK1, ASK1, or TAK1 (Minden and Karin 1997; Ip and Davis 1998). Like the p38 pathway, the SAPK/JNK pathway can be activated by a variety of cellular stresses that include genotoxic stress, free radicals, heat shock, osmotic shock, ischemia, and proinflammatory cytokines such as tumor necrosis factor-
and interleukin-1β (Minden and Karin 1997; Ip and Davis 1998). When activated, SAPK/JNK can phosphorylate and activate c-Jun or other transcription factors including ATF-2 and Elk-1 (Gupta et al. 1995; Minden et al. 1995; Yang et al. 1998). Although the physiological role of SAPK/JNK is not fully understood, SAPK/JNK has been shown to be involved in the cellular mechanism of apoptotic cell death under certain conditions (Minden and Karin 1997; Ip and Davis 1998). In particular, a series of studies using mice have demonstrated a pivotal role of SAPK/JNK in apoptotic cell death and excitotoxic neuronal death (Yang et al. 1997; Dong et al. 1998; Kuan et al. 1999; Tournier et al. 2000).
To better understand the intracellular signaling downstream of PS1, we investigated whether PS1 could modulate the MAPK signaling pathways. We report in this study that PS1 inhibits the SAPK/JNK pathway and that the PS1-induced suppression of the SAPK/JNK pathway requires functionally active PS1. Our findings suggest that PS1 inhibits stress-activated signaling by suppressing the SAPK/JNK pathway.
| Materials and Methods |
|---|
|
|
|---|
MEKK1, and pEXV-Rac1V12 (A. Hall, University College London, London, UK) were described previously (Shim et al. 1996, Shim et al. 2000).
Cell Culture and DNA Transfection
Human embryonic kidney (HEK) 293 cells, B103 rat neuroblastoma cells, and mouse embryonic fibroblasts (MEFs) from wild-type or PS1-null mice (Shen et al. 1997) were grown in DME (GIBCO BRL) supplemented with 10% fetal bovine serum. MEFPS1(+/+) and MEFPS1(–/–) cells (J. Shen, Brigham and Women's Hospital, Harvard Medical School, Boston, MA) at the passage between three and six were used, and they were in the same passage at the experiments. Cultured cells were transfected by calcium phosphate method or LipofectAMINE (GIBCO BRL). To establish cells that stably expressed ectopic PS1, B103 cells were transfected with pcDNA3 empty vector or pcDNA3-PS1. After 48 h of transfection, the cells were maintained in complete medium containing 500 µg/ml G418 to select neomycin-resistant cells. Expression of ectopic PS1 in the neomycin-resistant cells was analyzed by immunoblot using anti-PS1 antibody.
Apoptosis Assay
After the proper treatments, cultured cells were fixed with 70% ethanol on ice for 1 h and then stained with 10 µg/ml propidium iodide. The propidium iodide–stained cells were analyzed by flow cytometry (FACSCalibur®; Becton Dickinson). Alternatively, cells were transfected with indicated vector constructs plus pEGFP. After 24 h of transfection, the cells were treated with indicated apoptotic stimuli. The cells were fixed with 4% formaldehyde for 30 min and then stained with 10 µg/ml of DAPI for 10 min. The DAPI-stained nuclei were examined for apoptotic morphology with a ZEISS Axiovert fluorescence microscope. Green fluorescent protein (GFP)–expressing cells were scored for apoptotic nuclei. More than 200 cells were counted in each experiment, and data from three independent experiments were analyzed.
Immune Complex Kinase Assay
Cultured cells were lysed in a lysis buffer, and the cell lysates were subjected to immunoprecipitation using appropriate antibodies (Park et al. 2000; Shim et al. 2000). The resultant immunopellets were assayed for activities of the indicated protein kinases (Park et al. 2000). GST–c-Jun (1–79) was used as a substrate for SAPK/JNK, GST–ATF2 (1–109) for p38, myelin basic protein for Erk2, GST–SAPKβ(K55R) for SEK1, and GST–SEK1(K129R) for MEKK1. The phosphorylated proteins were resolved by SDS-PAGE on a 10% polyacrylamide gel and analyzed with a Fuji BAS 2500 PhosphorImager. The cell lysates were also subjected to immunoblot analysis using the indicated antibodies. The bands in the immunoblot were visualized using an enhanced chemiluminescence system (Amersham Pharmacia Biotech).
| Results |
|---|
|
|
|---|
|
MEKK1 (Fig. 2 C). These results suggest that PS1 might suppress the SAPK/JNK pathway by acting on a site or sites upstream of MEKK1. Rac1, a member of the small GTP-binding protein Rho family, has been shown to act upstream of MEKK1 to stimulate the SAPK/JNK pathway (Coso et al. 1995; Minden et al. 1995). Overexpression of Rac1V12, a constitutively active mutant of Rac1, induced SAPK stimulation in transfected HEK293 cells (Fig. 2 D), and PS1 did not repress the Rac1V12-induced SAPK stimulation. This suggests that PS1 may inhibit the SAPK/JNK pathway by acting on a site upstream of Rac1 or by a pathway independent of the Rac1-mediated signaling.
|
-secretase activation (Wolfe et al. 1999). The UV-induced SAPK stimulation was also repressed by overexpression of PS1
Ex9 (Fig. 3 B). PS1
Ex9 is a functional PS1 mutant lacking exon 9 (amino acids 290–319), which contains an endoproteolytic site, M298 (Thinakaran et al. 1996; Podlisny et al. 1997). Thus, PS1
Ex9 does not undergo endoproteolysis but is competent for
-secretase activation (Li et al. 2000). Our data, therefore, suggest that
-secretase activation may be important for PS1 to suppress the SAPK/JNK pathway.
|
|
MEKK1 overexpression was also repressed in B103 cells transfected with SEK1(K129R) (Fig. 5 B). These results suggest that the SAPK/JNK signaling cascade is involved in the mechanism of the H2O2- or
MEKK1-induced apoptosis in B103 cells. Overexpressed PS1 prevented apoptotic cell death induced by H2O2 (Fig. 5 A), but not by
MEKK1 (Fig. 5 B). These data suggest that PS1 might prevent the H2O2-induced apoptotic cell death through inhibiting the SAPK/JNK pathway and that the inhibition occurs a site upstream of MEKK1 in the SAPK/JNK pathway. Our data also show that PS1
Ex9, which retains an ability of
-secretase activation (Li et al. 2000) and suppressed the SAPK/JNK pathway (Fig. 3), also inhibited H2O2-induced apoptotic cell death (Fig. 5 A). In contrast, PS1(D257A), which lacks an ability of
-secretase activation (Wolfe et al. 1999) and could not suppress the SAPK pathway (Fig. 3), failed to block the H2O2-induced apoptotic cell death.
|
stimulation in MEF cells from PS1+/+ and PS1–/– mice (Shen et al. 1997). Interestingly, the endogenous JNK1/SAPK
activity both at the basal state and in the H2O2-stimulated state was higher in MEFPS1(–/–) cells than in MEFPS1(+/+) cells (Fig. 6 A). Ectopic expression of PS1 in the MEFPS1(–/–) cells resulted in a decrease in the H2O2-stimulated SAPK/JNK activity (Fig. 6 B). We also examined H2O2-induced apoptotic cell death in MEFPS1(+/+) and MEFPS1(–/–) cells. MEFPS1(–/–) cells were more sensitive to H2O2-induced apoptosis than MEFPS1(+/+) cells (Fig. 6 C). Furthermore, overexpressed PS1 converted MEFPS1(–/–) cells to be more resistant to H2O2-induced apoptosis (Fig. 6 D). On the other hand, biologically inactive PS1(D257A), which failed to suppress the SAPK pathway (Fig. 3), did not lower the H2O2-induced apoptotic cell death in the MEFPS1(–/–) cells. Together, these data strongly suggest that PS1 functions as a negative regulator of the SAPK/JNK pathway and that PS1 suppresses H2O2-induced apoptosis by inhibiting the SAPK/JNK pathway.
|
| Discussion |
|---|
|
|
|---|
-secretase activation and PS1 endoproteolysis (Wolfe et al. 1999), failed to inhibit SAPK stimulation. Furthermore, PS1
Ex9, which lacks the endoproteolysis site but is competent for activation of
-secretase activity (Li et al. 2000), retained the inhibitory effect on the SAPK/JNK pathway. These data suggest that the
-secretase activation, rather than the PS1 endoproteolysis, is required for the PS1-induced inhibition of the SAPK/JNK pathway.
-Secretase has two major substrates, APP and Notch (De Strooper et al. 1998, De Strooper et al. 1999). The cleavage of APP or Notch by
-secretase produces Aβ or the intracellular domain of Notch, Notch-IC, respectively. Aβ1–42 did not inhibit the SAPK/JNK activity (data not shown). In comparison, our preliminary data showed that overexpression of the Notch intracellular domain, which is the active form of intracellular Notch, resulted in suppression of SAPK/JNK activation (data not shown). These findings imply that PS1-mediated cleavage of Notch might be involved in the mechanism of PS1-induced suppression of the SAPK pathway. In this regard, Notch has been previously proposed to play a role in the regulation of the SAPK/JNK pathway (Ordentlich et al. 1998; Zecchini et al. 1999). Several lines of evidence suggest that presenilins are involved in apoptosis (Kim and Tanzi 1997; Kim et al. 1997). Overexpression of PS2 has been shown to potentiate apoptosis of PC12 cells induced by NGF withdrawal or neurotoxic Aβ1–42 (Wolozin et al. 1998). Another study showed that ALG3, a truncated form of murine PS2, reduced T cell receptor– or Fas-induced apoptosis in a mouse T cell hybridoma (Vito et al. 1996). Studies using PS1-null mice have demonstrated that PS1 is involved in neuronal survival (Shen et al. 1997). In this study, we show that ectopic PS1 suppressed the H2O2-induced apoptosis in B103 neuroblastoma cells. Moreover, deficiency of PS1 caused an elevation in the H2O2-induced apoptosis in MEF cells from PS1-null mice, as compared with MEF cells from PS1+/+ wild-type mice. The H2O2-induced apoptosis was blocked by overexpression of SEK1(K129R), suggesting that the SAPK/JNK pathway is involved in the mechanism of the H2O2-induced apoptosis. Thus, our findings suggest that PS1, by inhibiting the SAPK pathway, can protect cells from stress-induced apoptotic cell death. The precise mechanism by which PS1 inhibits the SAPK/JNK pathway, however, needs to be further studied.
| Acknowledgments |
|---|
This work was supported by the Creative Research Initiatives Program of the Korean Ministry of Science and Technology (to E.-J. Choi).
Submitted: 2 November 2000
Revised: 14 March 2001
Accepted: 19 March 2001
J.W. Kim and T.-S. Chang contributed equally to this work and should be considered co-first authors.
| References |
|---|
|
|
|---|
Artavanis-Tsakonas S., Rand M.D. & Lake R.J.. Notch signalingcell fate control and signal integration in development, Science, 284, 1999, 770–776.
Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H. & Yancopoulos G.D.. ERKsa family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF, Cell, 65, 1991, 663–675.[Medline]
Chan Y.M. & Jan Y.N.. Presenilins, processing of β-amyloid precursor protein, and notch signaling, Neuron, 23, 1999, 201–204.[Medline]
Cobb M.H. & Goldsmith E.J.. How MAP kinases are regulated, J. Biol. Chem., 270, 1995, 14843–14846.
Cook D.G., Sung J.C., Golde T.E., Felsenstein K.M., Wojczyk B.S., Tanzi R.E., Trojanowski J.Q., Lee V.M. & Doms R.W.. Expression and analysis of presenilin 1 in a human neuronal systemlocalization in cell bodies and dendrites, Proc. Natl. Acad. Sci. USA, 93, 1996, 9223–9228.
Coso O.A., Chiariello M., Yu J.C., Teramoto H., Crespo P., Xu N., Miki T. & Gutkind J.S.. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway, Cell., 81, 1995, 1137–1146.[Medline]
De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., George-Hyslop P.S. & Van Leuven F.. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins, J. Biol. Chem., 272, 1997, 3590–3598.
De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K. & Van Leuven F.. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein, Nature, 391, 1998, 387–390.[Medline]
De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., Schroeter E.H., Schrijvers V., Wolfe M.S. & Ray W.J.. A presenilin-1-dependent
-secretase-like protease mediates release of Notch intracellular domain, Nature, 398, 1999, 518–522.[Medline]
Doan A., Thinakaran G., Borchelt D.R., Slunt H.H., Ratovitsky T., Podlisny M., Selkoe D.J., Seeger M., Gandy S.E., Price D.L. & Sisodia S.S.. Protein topology of presenilin 1, Neuron., 17, 1996, 1023–1030.[Medline]
Dong C., Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J. & Flavell R.A.. Defective T cell differentiation in the absence of Jnk1, Science, 282, 1998, 2092–2095.
Fanger G.R., Gerwins P., Widmann C., Jarpe M.B. & Johnson G.L.. MEKKs, GCKs, MLKs, PAKs, TAKs, and tplsupstream regulators of the c-Jun amino-terminal kinases?, Curr. Opin. Genet. Dev, 7, 1997, 67–74.[Medline]
Gupta S., Campbell D., Derijard B. & Davis R.J.. Transcription factor ATF2 regulation by the JNK signal transduction pathway, Science, 267, 1995, 389–393.
Han J., Lee J.D., Bibbs L. & Ulevitch R.J.. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells, Science, 265, 1994, 808–811.
Ip Y.T. & Davis R.J.. Signal transduction by the c-Jun N-terminal kinase (JNK)—from inflammation to development, Curr. Opin. Cell Biol., 10, 1998, 205–219.[Medline]
Kim T.W. & Tanzi R.E.. Presenilins and Alzheimer's disease, Curr. Opin. Neurobiol., 7, 1997, 683–688.[Medline]
Kim T.W., Pettingell W.H., Jung Y.K., Kovacs D.M. & Tanzi R.E.. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease, Science., 277, 1997, 373–376.
Kovacs D.M., Fausett H.J., Page K.J., Kim T.W., Moir R.D., Merriam D.E., Hollister R.D., Hallmark O.G., Mancini R. & Felsenstein K.M.. Alzheimer-associated presenilins 1 and 2neuronal expression in brain and localization to intracellular membranes in mammalian cells, Nat. Med, 2, 1996, 224–229.[Medline]
Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P. & Flavell R.A.. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development, Neuron, 22, 1999, 667–676.[Medline]
Kyriakis J.M. & Avruch J.. Protein kinase cascades activated by stress and inflammatory cytokines, Bioessays, 18, 1996, 567–577.[Medline]
Levitan D. & Greenwald I.. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene, Nature, 377, 1995, 351–354.[Medline]
Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D. & Wang K.. Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science, 269, 1995, 973–977.
Li X. & Greenwald I.. HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling, Proc. Natl. Acad. Sci. USA., 94, 1997, 12204–12209.
Li Y.-M., Xu M., Lai M.-T., Huang Q., Casto J.L., DiMuzio-Mower J., Harrison T., Lellis C., Nadin A. & Neduvelil J.G.. Photoactivated
-secretase inhibitors directed to the active site covalently label presenilin 1, Nature, 405, 2000, 689–694.[Medline]
Minden A. & Karin M.. Regulation and function of the JNK subgroup of MAP kinases, Biochim. Biophys. Acta, 1333, 1997, F85–F104.[Medline]
Minden A., Lin A., Claret F.X., Abo A. & Karin M.. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs, Cell, 81, 1995, 1147–1157.[Medline]
Ordentlich P., Lin A., Shen C.P., Blaumueller C., Matsuno K., Artavanis-Tsakonas S. & Kadesch T.. Notch inhibition of E47 supports the existence of a novel signaling pathway, Mol. Cell. Biol, 18, 1998, 2230–2239.
Park H.S., Park E., Kim M.S., Ahn K., Kim I.Y. & Choi E.J.. Selenite inhibits the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) through a thiol redox mechanism, J. Biol. Chem, 275, 2000, 2527–2531.
Podlisny M.B., Citron M., Amarante P., Sherrington R., Xia W., Zhang J., Diehl T., Levesque G., Fraser P. & Haass C.. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue, Neurobiol. Dis, 3, 1997, 325–337.[Medline]
Ray W.J., Yao M., Nowotny P., Mumm J., Zhang W., Wu J.Y., Kopan R. & Goate A.M.. Evidence for a physical interaction between presenilin and Notch, Proc. Natl. Acad. Sci. USA., 96, 1999, 3263–3268.
Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K. & Tsuda T.. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene, Nature, 376, 1995, 775–778.[Medline]
Schaeffer H.J. & Weber M.J.. Mitogen-activated protein kinasesspecific messages from ubiquitous messengers, Mol. Cell. Biol, 19, 1999, 2435–2444.
Selkoe E.J.. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease, Trends Cell Biol., 8, 1998, 447–453.[Medline]
Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J. & Tonegawa S.. Skeletal and CNS defects in presenilin-1-deficient mice, Cell, 89, 1997, 629–639.[Medline]
Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G. & Holman K.. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, 375, 1995, 754–760.[Medline]
Shim J., Lee H., Park J., Kim H. & Choi E.J.. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases, Nature, 381, 1996, 804–806.[Medline]
Shim J., Park H.S., Kim M.J., Park J., Park E., Cho S.G., Eom S.J., Lee H.W., Joe C.O. & Choi E.J.. Rb protein down-regulates the stress-activated signals through inhibiting c-Jun N-terminal kinase/stress-activated protein kinase, J. Biol. Chem, 275, 2000, 14107–14111.
Su B. & Karin M.. Mitogen-activated protein kinase cascades and regulation of gene expression, Curr. Opin. Immunol, 8, 1996, 402–411.[Medline]
Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C. & Seeger M.. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo, Neuron, 17, 1996, 181–190.[Medline]
Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A. & Davis R.J.. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway, Science, 288, 2000, 870–874.
Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., Birrer M.J., Szabo E., Zon L.I. & Kyriakis J.M.. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis, Nature, 380, 1996, 75–79.[Medline]
Vito P., Lacana E. & D'Adamio L.. Interfering with apoptosisCa2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3, Science, 271, 1996, 521–525.[Abstract]
Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T. & Selkoe D.J.. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and
-secretase activity, Nature, 398, 1999, 513–517.[Medline]
Wolozin B., Alexander P. & Palacino J.. Regulation of apoptosis by presenilin 1, Neurobiol. Aging, 19, 1998, S23–S27.[Medline]
Xia Z., Dickens M., Raingeaud J., Davis R.J. & Greenberg M.E.. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis, Science, 270, 1995, 1326–1331.
Yang D.D., Kuan C.-Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P. & Flavell R.A.. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene, Nature, 389, 1997, 865–870.[Medline]
Yang S.H., Whitmarsh A.J., Davis R.J. & Sharrocks A.D.. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1, EMBO (Eur. Mol. Biol. Organ.) J., 17, 1998, 1740–1749.[Medline]
Zecchini V., Brennan K. & Martinez-Arias A.. An activity of Notch regulates JNK signaling and affects dorsal closure in Drosophila, Curr. Biol., 9, 1999, 460–469.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|